NO964567D0 - Våtgranuleringsformulering for bisfosfonsyrer - Google Patents

Våtgranuleringsformulering for bisfosfonsyrer

Info

Publication number
NO964567D0
NO964567D0 NO964567A NO964567A NO964567D0 NO 964567 D0 NO964567 D0 NO 964567D0 NO 964567 A NO964567 A NO 964567A NO 964567 A NO964567 A NO 964567A NO 964567 D0 NO964567 D0 NO 964567D0
Authority
NO
Norway
Prior art keywords
wet granulation
bisphosphonic acids
binder
prepared
treatment
Prior art date
Application number
NO964567A
Other languages
English (en)
Norwegian (no)
Other versions
NO964567L (no
Inventor
Ashok V Katdare
Kenneth A Kramer
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22891482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964567(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO964567L publication Critical patent/NO964567L/no
Publication of NO964567D0 publication Critical patent/NO964567D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO964567A 1994-04-29 1996-10-28 Våtgranuleringsformulering for bisfosfonsyrer NO964567D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23690494A 1994-04-29 1994-04-29
PCT/US1995/004965 WO1995029679A1 (fr) 1994-04-29 1995-04-24 Composition pour acides bisphosphoniques a granulation par voie humide

Publications (2)

Publication Number Publication Date
NO964567L NO964567L (no) 1996-10-28
NO964567D0 true NO964567D0 (no) 1996-10-28

Family

ID=22891482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964567A NO964567D0 (no) 1994-04-29 1996-10-28 Våtgranuleringsformulering for bisfosfonsyrer

Country Status (32)

Country Link
EP (1) EP0756484B1 (fr)
JP (1) JP3838658B2 (fr)
KR (1) KR100390719B1 (fr)
CN (2) CN1147202A (fr)
AT (1) ATE225661T1 (fr)
AU (1) AU694217C (fr)
BG (1) BG62878B1 (fr)
CA (1) CA2188567C (fr)
CO (1) CO4560546A1 (fr)
CZ (1) CZ291574B6 (fr)
DE (1) DE69528525T2 (fr)
DK (1) DK0756484T3 (fr)
ES (1) ES2183873T3 (fr)
FI (1) FI118206B (fr)
HR (1) HRP950261B1 (fr)
HU (1) HUT76297A (fr)
IL (1) IL113465A (fr)
LV (1) LV13114B (fr)
MX (1) MX9605222A (fr)
MY (1) MY120491A (fr)
NO (1) NO964567D0 (fr)
NZ (1) NZ284719A (fr)
PL (1) PL316987A1 (fr)
PT (1) PT756484E (fr)
RU (1) RU2149003C1 (fr)
SA (1) SA95160013B1 (fr)
SK (1) SK283785B6 (fr)
TW (1) TW390813B (fr)
UA (1) UA44733C2 (fr)
WO (1) WO1995029679A1 (fr)
YU (1) YU49458B (fr)
ZA (1) ZA953437B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PL337813A1 (en) * 1997-06-11 2000-09-11 Procter & Gamble Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
IL121623A (en) * 1997-08-26 2000-06-29 Unipharm Ltd Process for the preparation of solid oral dosage forms comprising alendronic acid
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
EP0998933A1 (fr) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Procédé pour la préparation de compositions pharmaucetiques contenant des diphosphonates pour administration orale
EP0998932A1 (fr) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Forme d'administration pharmaceutique contenant des diphosphonates ou leurs sels et méthode pour la fabriquer
GB9911926D0 (en) * 1999-05-21 1999-07-21 Okuno Tetsuji Organic compounds
DK1178810T3 (da) * 1999-05-21 2005-07-11 Novartis Ag Anvendelse af bisphosphonsyrer til behandling af angiogenese
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
KR20140021045A (ko) 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
NZ536273A (en) † 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
RS20060009A (sr) * 2003-07-11 2008-06-05 F.Hoffmann-La Roche Ag., Oralni oblik za doziranje sakvinavir mezilata
CA2631492A1 (fr) * 2005-12-15 2007-06-21 Acusphere, Inc. Procedes de preparation de formulations pharmaceutiques a base de particules destinees a une administration orale
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
KR102622198B1 (ko) * 2018-03-30 2024-01-09 한미약품 주식회사 빌다글립틴을 함유하는 경구용 고형제제 및 그의 제조 방법
CN112972400A (zh) * 2021-03-09 2021-06-18 华侨大学 可快速崩解的米诺膦酸颗粒及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4711886A (en) * 1984-07-02 1987-12-08 Merck & Co., Inc. β-lactam derivatives as anti-inflammatory and antidegenerative agents
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
FI89366C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
TW237386B (fr) * 1992-04-15 1995-01-01 Ciba Geigy
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .

Also Published As

Publication number Publication date
ATE225661T1 (de) 2002-10-15
RU2149003C1 (ru) 2000-05-20
IL113465A (en) 2005-09-25
MY120491A (en) 2005-11-30
AU694217C (en) 2005-12-15
CA2188567A1 (fr) 1995-11-09
HUT76297A (en) 1997-07-28
EP0756484A1 (fr) 1997-02-05
CA2188567C (fr) 2007-02-20
MX9605222A (es) 1997-09-30
YU49458B (sh) 2006-03-03
TW390813B (en) 2000-05-21
UA44733C2 (uk) 2002-03-15
CO4560546A1 (es) 1998-02-10
PT756484E (pt) 2002-12-31
BG62878B1 (bg) 2000-10-31
FI964315A0 (fi) 1996-10-25
CZ315296A3 (en) 1997-04-16
YU27395A (sh) 1998-07-10
DE69528525T2 (de) 2003-11-27
SK283785B6 (sk) 2004-01-08
PL316987A1 (en) 1997-03-03
AU2393995A (en) 1995-11-29
CN1147202A (zh) 1997-04-09
DE69528525D1 (de) 2002-11-14
JP3838658B2 (ja) 2006-10-25
FI118206B (fi) 2007-08-31
SA95160013B1 (ar) 2005-11-23
ES2183873T3 (es) 2003-04-01
EP0756484B1 (fr) 2002-10-09
HRP950261A2 (en) 1997-02-28
BG100911A (en) 1997-07-31
JPH09512551A (ja) 1997-12-16
HRP950261B1 (en) 2003-08-31
HU9602986D0 (en) 1997-01-28
FI964315L (fi) 1996-10-25
IL113465A0 (en) 1995-07-31
ZA953437B (en) 1996-01-17
DK0756484T3 (da) 2002-11-25
NO964567L (no) 1996-10-28
LV13114B (en) 2004-06-20
KR970702050A (ko) 1997-05-13
HK1009246A1 (en) 1999-05-28
SK139096A3 (en) 1997-05-07
CN1781489A (zh) 2006-06-07
KR100390719B1 (ko) 2003-10-17
AU694217B2 (en) 1998-07-16
NZ284719A (en) 1998-06-26
CZ291574B6 (cs) 2003-04-16
WO1995029679A1 (fr) 1995-11-09

Similar Documents

Publication Publication Date Title
NO964567L (no) Våtgranuleringsformulering for bisfosfonsyrer
CA2149052A1 (fr) Formulations sous forme de melange sec pour acides bisphosphoniques
CY1106482T1 (el) Φαρμακευτικη παρεντepικη συνθεση πepιεχοντας ενα διφωσφονικο
TR199800767T2 (xx) Proteaz engelleyicileri.
TWI289451B (en) Use of a bisphosphonate for the manufacture of a medicament for the treatment of conditions of abnormally increased bone turnover
NZ332314A (en) Oral pharmaceutical preparation containing ibandronate or salts thereof in the form of an inner section containing the active ingredient surrounded by a coating free of the active ingredient
DE60239343D1 (de) Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
DK1914237T3 (da) Antivirale fosfonatesterforbindelser
IL104109A0 (en) Pharmaceutical compositions containing aldenorate for treating periodontal diseases
FI110667B (fi) Menetelmä farmaseuttisen valmisteen valmistamiseksi
NZ527157A (en) Compositions for delivering bisphosphonates
CA2024694A1 (fr) Acyloxymethyl esters de l'acide bisphosphonique utilises comme inhibiteurs de la resorption osseuse
CA2035179A1 (fr) Composition pharmaceutique contenant des sels insolubles d'acides biphosphonique
WO2004058235A3 (fr) Methode pouvant augmenter la biodisponibilite d'alendronate ou autre diphosphonate par administration d'une predose d'un derive de la vitamine d
EP0341961A3 (fr) Acides polymaloniques comme agents ayant une affinité osseuse
BR9808233A (pt) Preparação farmacêutica
ATE330616T1 (de) Verabreichung von bisphosphonaten durch inhalation zur behandlung von knochenresorption und osteoporosis
IS1801B (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
EA200100080A1 (ru) Лекарственные средства, содержащие бисфосфоновые кислоты и их производные, предназначенные для профилактики и лечения аутоиммунных заболеваний и аллергий
EP0612246A4 (fr) Compositions pharmaceutiques comprenant des complexes au gallium de 3-hydroxy-4-pyrones.
BR0106601A (pt) Composição farmacêutica contendo bisfosfonato para o tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato, seu uso na preparação de medicamento para o tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato, método de tratamento de doenças relacionadas ao metabolismo de cálcio e/ou fosfato
IL141218A0 (en) Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption
GEP20002179B (en) Means for Treatment of Herpes